Page last updated: 2024-11-07

n-(2-acetamido)iminodiacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(2-acetamido)iminodiacetic acid (ADA) is a chelating agent with a high affinity for various metal ions, particularly copper. Its synthesis typically involves the reaction of iminodiacetic acid with 2-acetamidoethanol. ADA has been extensively studied for its potential applications in various fields, including:
- **Metal ion complexation and removal:** ADA's strong chelating ability makes it effective in sequestering metal ions from solutions, with applications in water treatment and metal recovery.
- **Biomedical applications:** ADA's copper complex has been investigated for its potential use in treating copper-related disorders, such as Wilson's disease.
- **Analytical chemistry:** ADA is used as a reagent in analytical chemistry for the determination of metal ions, forming stable complexes that can be quantified using various analytical techniques.
- **Catalysis:** ADA and its metal complexes can serve as catalysts in various organic reactions, promoting selective transformations.
ADA is a versatile compound with diverse applications stemming from its ability to bind metal ions. Ongoing research continues to explore its potential in various fields.'

N-(2-acetamido)iminodiacetic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,2'-[(2-amino-2-oxoethyl)imino]diacetic acid : A tricarboxylic acid amide that is a Good's buffer substance, pKa = 6.6 at 20 degreeC. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID117765
CHEBI ID43960
SCHEMBL ID233033
MeSH IDM0073686

Synonyms (58)

Synonym
STL355999
(carbamoylmethyl-carboxymethyl-amino)-acetic acid
ADA ,
n-(2-acetamido)iminodiacetic acid
ada, bioxtra, >=98% (titration)
ada, >=98% (titration)
carbamoylmethylaminodiacetic acid
2,2'-[(2-amino-2-oxoethyl)imino]diacetic acid
26239-55-4
CHEBI:43960
n-carbamoylmethyliminodi(acetic acid)
n-(2-amino-2-oxoethyl)-n-(carboxymethyl)glycine
DB02810
n-(carbamoylmethyl)iminodiacetic acid
A0699
BMSE000146
glycine, n-(2-amino-2-oxoethyl)-n-(carboxymethyl)-
2-[(2-amino-2-oxoethyl)-(carboxymethyl)amino]acetic acid
AKOS005267103
unii-5c4r3o704e
5c4r3o704e ,
einecs 247-530-0
2,2'-((2-amino-2-oxoethyl)azanediyl)diacetic acid
c6h10n2o5
2-[(carbamoylmethyl)(carboxymethyl)amino]acetic acid
FT-0621892
S6310
BBL023210
SCHEMBL233033
ada [mi]
n-(carbamoylmethyl)iminodiacetatic acid
acetic acid, ((carbamoylmethyl)imino)di-
n-(2-acetamido)-iminodiacetic acid
DTXSID4067191
W-107186
n-[2-acetamido]iminodiacetic acid
QZTKDVCDBIDYMD-UHFFFAOYSA-N
n-(2-acetamido)imidodiacetic acid
iminodiacetic acid, n-(2-amino-2-oxoethyl)-
AKOS025395625
mfcd00008031
n-(2-acetamido)-2-iminodiacetic acid
AC-8316
ada, bioultra, >=99.0% (t)
ada, vetec(tm) reagent grade, >=98%
a d a
acetic acid, 2,2'-[(2-amino-2-oxoethyl)imino]bis-
SY048625
n-(carbamoylmethyl)-iminodiacetic acid
2,2'-(2-amino-2-oxoethylazanediyl)diacetic acid
Q27093765
AS-12375
ada buffer
D70536
CS-0015165
HY-D0855
EN300-1699288
Z1143273443
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
ADAA nitrogen molecular entity with role as Good's buffer.
dicarboxylic acidAny carboxylic acid containing two carboxy groups.
tricarboxylic acid amideA carboxamide resulting from the formal condensation of one or more carboxy groups of a tricarboxylic acid with the amino group of any amino compound.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (42.86)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.93 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]